Merck KGaA Completes Millipore Acquisition and Launches New Merck Millipore Division
Merck Chemicals now comprises two new divisions: Merck Millipore and Performance Materials
Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading life science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately EUR 5.2 billion (US$ 7.0 billion). Merck agreed to acquire Millipore on February 28, 2010 for US$107 in cash per share of Millipore common stock. The closing follows the approval of the acquisition by Millipore’s shareholders at a special meeting held on June 3, 2010 and the satisfaction of other customary conditions, including antitrust clearance in the United States and Europe.
Merck will now begin the process of de-listing the shares of Millipore from the New York Stock Exchange and removing the shares from registration with the U.S. Securities and Exchange Commission.
Other news from the department business & finance
